Skip to main content
logo
Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
4.420
+0.190 (4.49%)
At close: Aug 3, 2026, 4:00 PM EDT
4.370
-0.050 (-1.13%)
After-hours: Aug 3, 2026, 4:10 PM EDT

Ironwood Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
102.1824.020.88-1,032175.07528.45
Depreciation & Amortization
1.851.882.011.581.421.52
Stock-Based Compensation
15.6117.2529.8532.0127.0522.28
Other Adjustments
62.7344.2571.631,17067.41-310.09
Change in Receivables
-66.0735.1547.240.927.997.71
Changes in Accounts Payable
-8.356.2-20.2112.58-1.12-2.64
Changes in Accrued Expenses
-4.15-4.11-14.65-5.88-10.6414
Changes in Other Operating Activities
8.342.41-13.23.8514.46-1.46
Operating Cash Flow
112.21127.04103.55183.43273.76261.9
Operating Cash Flow Growth
42.91%22.69%-43.55%-33.00%4.53%55.12%
Capital Expenditures
-0-0.03-0.14-0.27-0.14-0.27
Cash Acquisitions
----1,026--
Investing Cash Flow
-0-0.03-0.14-1,026-0.14-0.27
Short-Term Debt Issued
--150400--
Short-Term Debt Repaid
---65-100--
Net Short-Term Debt Issued (Repaid)
--85300--
Long-Term Debt Repaid
---200--120.7-
Net Long-Term Debt Issued (Repaid)
---200--120.7-
Issuance of Common Stock
0.210.2211.016.369.5419.58
Repurchase of Common Stock
---0.74--126.39-24.13
Net Common Stock Issued (Repurchased)
0.210.2210.286.36-116.85-4.55
Other Financing Activities
---2.25-29.2--
Financing Cash Flow
0.210.22-106.97277.16-237.55-4.55
Foreign Exchange Rate Adjustments
-0.43-0.33-0.03-0.05--
Net Cash Flow
111.99126.9-3.6-565.7836.07257.08
Free Cash Flow
112.21127.01103.41183.15273.63261.63
Free Cash Flow Growth
43.10%22.82%-43.54%-33.06%4.58%56.67%
FCF Margin
31.04%42.89%29.43%41.37%66.64%63.23%
Free Cash Flow Per Share
0.660.780.651.181.471.59
Levered Free Cash Flow
99.8530.37-160.31-1,722233.421,068
Unlevered Free Cash Flow
278.76169.57138.81-850.32331.04-136
SEC Filings: 10-K · 10-Q